Autoimmunity versus tolerance: Can dying cells tip the balance?

Clinical Immunology

Volumn 122, Issue 2, 2007, Pages 125-134

  Viorritto, Irene C B ^a,b   Nikolov, Nikolay P ^c   Siegel, Richard M ^b,c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; AUTOANTIBODY; BETA INTERFERON; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4 BINDING PROTEIN; CYTOCHROME P450 1B1; DEOXYRIBONUCLEASE I; DNA ANTIBODY; IMMUNOGLOBULIN M; LACTADHERIN; MANNOSE BINDING LECTIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANOIKIS; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNITY; AUTOPHAGY; B LYMPHOCYTE; CELL DEATH; CHROMATIN; DENDRITIC CELL; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLOMERULONEPHRITIS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MOUSE STRAIN; NEPHRITIS; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SHORT SURVEY; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE TOLERANCE;

EID: 33846054490     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.07.012     Document Type: Short Survey

References (69)

1. Aigner T. Apoptosis, necrosis, or whatever: how to find out what really happens?. J. Pathol. 198 (2002) 1-4
2. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
3. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., and van Kooten C. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur. J. Immunol. 34 (2004) 921-929
4. Manjili M.H., Park J., Facciponte J.G., and Subjeck J.R. HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology 210 (2005) 295-303
5. Denecker G., Vercammen D., Steemans M., Vanden Berghe T., Brouckaert G., Van Loo G., Zhivotovsky B., Fiers W., Grooten J., Declercq W., and Vandenabeele P. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ. 8 (2001) 829-840
6. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., Baehrecke E.H., and Lenardo M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304 (2004) 1500-1502
7. Zhan M., Zhao H., and Han Z.C. Signalling mechanisms of anoikis. Histol. Histopathol. 19 (2004) 973-983
8. Rock K.L., York I.A., Saric T., and Goldberg A.L. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 80 (2002) 1-70
9. Albert M.L., Sauter B., and Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392 (1998) 86-89
10. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., and Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191 (2000) 423-434
11. Steinman R.M., Turley S., Mellman I., and Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191 (2000) 411-416
12. Delamarre L., Holcombe H., and Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198 (2003) 111-122
13. Ferguson T.A., Herndon J., Elzey B., Griffith T.S., Schoenberger S., and Green D.R. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J. Immunol. 168 (2002) 5589-5595
14. Schulz O., and Reis e Sousa C. Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107 (2002) 183-189
15. Scheinecker C., McHugh R., Shevach E.M., and Germain R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196 (2002) 1079-1090
16. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., and MacPherson G.G. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191 (2000) 435-444
17. Inaba K., Turley S., Iyoda T., Yamaide F., Shimoyama S., Reis e Sousa C., Germain R.N., Mellman I., and Steinman R.M. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191 (2000) 927-936
18. Davey G.M., Kurts C., Miller J.F., Bouillet P., Strasser A., Brooks A.G., Carbone F.R., and Heath W.R. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J. Exp. Med. 196 (2002) 947-955
19. Lambolez F., Jooss K., Vasseur F., and Sarukhan A. Tolerance induction to self antigens by peripheral dendritic cells. Eur. J. Immunol. 32 (2002) 2588-2597
20. Mayerova D., Parke E.A., Bursch L.S., Odumade O.A., and Hogquist K.A. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21 (2004) 391-400
21. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
22. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54 (1989) 1-13
23. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
24. Schulz O., Diebold S.S., Chen M., Naslund T.I., Nolte M.A., Alexopoulou L., Azuma Y.T., Flavell R.A., Liljestrom P., and Reis e Sousa C. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433 (2005) 887-892
25. Sporri R., and Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6 (2005) 163-170 (Electronic publication 2005 Jan 2016)
26. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
27. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., and Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202 (2005) 321-331
28. Clarkson Jr. A.B., and Mellow G.H. Rheumatoid factor-like immunoglobulin M protects previously uninfected rat pups and dams from Trypanosoma lewisi. Science 214 (1981) 186-188
29. Coulie P., and Van Snick J. Rheumatoid factors and secondary immune responses in the mouse: II. Incidence, kinetics and induction mechanisms. Eur. J. Immunol. 13 (1983) 895-899
30. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematsu S., Kawai T., Takeuchi O., and Akira S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7 (2006) 40-48
31. Okabe Y., Kawane K., Akira S., Taniguchi T., and Nagata S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202 (2005) 1333-1339
32. Stetson D.B., and Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24 (2006) 93-103
33. Gallucci S., Lolkema M., and Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5 (1999) 1249-1255
34. Heath W.R., and Carbone F.R. Immunology: dangerous liaisons. Nature 425 (2003) 460-461
35. Shi Y., Evans J.E., and Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 (2003) 516-521 (Electronic publication 2003 Sep 2007)
36. Martinon F., Petrilli V., Mayor A., Tardivel A., and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006) 237-241
37. Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., Sonderegger I., Bachmaier K., Kopf M., and Penninger J.M. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9 (2003) 1484-1490
38. Heiring C., Dahlback B., and Muller Y.A. Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family. J. Biol. Chem. 279 (2004) 6952-6958 (Electronic publication 2003 Nov 6917)
39. Behrens E.M., Gadue P., Gong S.Y., Garrett S., Stein P.L., and Cohen P.L. The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity. Eur. J. Immunol. 33 (2003) 2160-2167
40. Fadok V.A., Warner M.L., Bratton D.L., and Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161 (1998) 6250-6257
41. Grimsley C., and Ravichandran K.S. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell. Biol. 13 (2003) 648-656
42. Savill J., Hogg N., Ren Y., and Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90 (1992) 1513-1522
43. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
44. Hanayama R., Tanaka M., Miyasaka K., Aozasa K., Koike M., Uchiyama Y., and Nagata S. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304 (2004) 1147-1150
45. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., and Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192 (2000) 359-366
46. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., and Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19 (1998) 56-59
47. Manderson A.P., Botto M., and Walport M.J. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22 (2004) 431-456
48. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., and Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85-90
49. Kunisaki Y., Masuko S., Noda M., Inayoshi A., Sanui T., Harada M., Sasazuki T., and Fukui Y. Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor. Blood 103 (2004) 3362-3364 (Electronic publication 2004 Jan 3308)
50. Li M.O., Sarkisian M.R., Mehal W.Z., Rakic P., and Flavell R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302 (2003) 1560-1563
51. Bose J., Gruber A.D., Helming L., Schiebe S., Wegener I., Hafner M., Beales M., Kontgen F., and Lengeling A. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J. Biol. 3 (2004) 15 (Electronic publication 2004 Aug 2023)
52. Cui P., Qin B., Liu N., Pan G., and Pei D. Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals. Exp. Cell Res. 293 (2004) 154-163
53. van Nieuwenhuijze A.E., van Lopik T., Smeenk R.J., and Aarden L.A. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus. Ann. Rheum. Dis. 62 (2003) 10-14
54. Lu Q., and Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293 (2001) 306-311
55. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., and Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411 (2001) 207-211
56. Asano K., Miwa M., Miwa K., Hanayama R., Nagase H., Nagata S., and Tanaka M. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200 (2004) 459-467
57. Ward J.M., Nikolov N.P., Tschetter J.R., Kopp J.B., Gonzalez F.J., Kimura S., and Siegel R.M. Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice. Toxicol. Pathol. 32 (2004) 710-718
58. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L., Kirchner T., Kalden J.R., and Herrmann M. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46 (2002) 191-201
59. Herrmann M., Voll R.E., Zoller O.M., Hagenhofer M., Ponner B.B., and Kalden J.R. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41 (1998) 1241-1250
60. Kalden J.R. Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE. Lupus 6 (1997) 326-327
61. Manson J.J., Mauri C., and Ehrenstein M.R. Natural serum IgM maintains immunological homeostasis and prevents autoimmunity. Springer Semin. Immunopathol. 26 (2005) 425-432
62. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., and Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25 (2000) 177-181
63. Tsukumo S., and Yasutomo K. DNAseI in pathogenesis of systemic lupus erythematosus. Clin. Immunol. 113 (2004) 14-18
64. Gaipl U.S., Beyer T.D., Heyder P., Kuenkele S., Bottcher A., Voll R.E., Kalden J.R., and Herrmann M. Cooperation between C1q and DNAse I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum. 50 (2004) 640-649
65. Munoz L.E., Gaipl U.S., Franz S., Sheriff A., Voll R.E., Kalden J.R., and Herrmann M. SLE-a disease of clearance deficiency?. Rheumatology (Oxford) 44 (2005) 1101-1107
66. Davis Jr. J.C., Manzi S., Yarboro C., Rairie J., McInnes I., Averthelyi D., Sinicropi D., Hale V.G., Balow J., Austin H., Boumpas D.T., and Klippel J.H. Recombinant human DNAse I (rhDNAse) in patients with lupus nephritis. Lupus 8 (1999) 68-76
67. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., Adams J.M., and Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 (1999) 1735-1738
68. Fisher G.H., Rosenberg F.J., Straus S.E., Dale J.K., Middleton L.A., Lin A.Y., Strober W., Lenardo M.J., and Puck J.M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81 (1995) 935-946
69. Chen M., Wang Y.H., Wang Y., Huang L., Sandoval H., Liu Y.J., and Wang J. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311 (2006) 1160-1164